Dataset from Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With COPD and Proven Hyperinflation

- Primary objective of this observational study was to gain insights into the effects of therapy with Spiriva® (tiotropium bromide) 18 microgram on the health-related quality of life and physical functioning in patients with chronic obstructive pulmonary disease (COPD) and demonstrated hyperinflation. - Secondary objective was to obtain safety data regarding adverse events.

- 本项观察性研究的主要研究目标为：探究18微克剂量的思力华®（Spiriva®，噻托溴铵，tiotropium bromide）疗法，对合并已证实存在肺过度充气的慢性阻塞性肺疾病（chronic obstructive pulmonary disease, COPD）患者的健康相关生活质量及躯体功能的影响。
- 次要研究目标为：获取与不良事件相关的安全性数据。